1. Description
Pancragen (also known as pancreatic regulatory peptide, Cytomidin) is an artificially synthesized four peptide biological regulator with an amino acid sequence of Lys Glu Asp Trp (KEDW) and a molecular weight of approximately 518.5 Da. It is composed of lysine, glutamic acid, aspartic acid, and tryptophan, with acidic and alkaline side chains forming a local charge balance. It has amphiphilicity and good cell membrane penetration, and can efficiently bind to biological membranes, chromatin, and protein targets. This peptide has excellent stability, with a purity of usually ≥ 98.5% in freeze-dried formulations and over 99% in most batches. It can be stored for a long time under low temperature and light avoidance conditions. Its core mechanism of action revolves around pancreatic tissue-specific targeting, upregulating key pancreatic transcription factors such as PDX1 and NGN3 through epigenetic regulation, gene expression regulation, and cell signaling pathway intervention. It activates silenced functional genes in aging or dysfunctional pancreatic cells, while inhibiting pancreatic cell apoptosis and the release of inflammatory factors (TNF - α), regulating the balance of insulin and glucagon secretion, repairing pancreatic gland function from the root and improving metabolic disorders. It is a pancreatic targeted bioactive peptide with both scientific research value and application potential.
2. Application
Pancragen's application scenarios cover four core areas: metabolic diseases, pancreatic diseases, digestive system health, and scientific drug development. In the field of metabolic diseases, for type 2 diabetes, insulin resistance, abnormal glucose tolerance, and metabolic syndrome, Pancragen can improve pancreatic beta cell function, reduce insulin resistance, and assist in controlling blood glucose and lipids. Pancragen is suitable for elderly and early diabetes patients and high-risk groups of diabetes; In the field of pancreatic diseases, chronic pancreatitis, age-related decline in pancreatic function, and pancreatic damage caused by alcohol, drugs, and surgery can alleviate tissue inflammation, promote pancreatic repair, and relieve symptoms such as abdominal pain and indigestion; In the field of digestive system health, targeted improvements can be made to the problem of insufficient secretion of digestive enzymes caused by pancreatic exocrine dysfunction, alleviating digestive discomfort such as diarrhea, fat diarrhea, postprandial fullness, and improving nutrient absorption rate; In the field of scientific research and drug development, as a tool peptide for the research of pancreatic cell differentiation and regeneration, it can be used in vitro cell experiments and animal models. It is also a high-quality lead compound for the research and development of new anti diabetes and anti pancreatic fibrosis drugs, which is suitable for multi scenario research and application needs.
3. Main Efficacy
The core efficacy of Pancragen focuses on pancreatic repair, metabolic regulation, digestive improvement, and tissue protection, with both health prevention and anti-aging values. In terms of pancreatic cell repair and regeneration, it can activate pancreatic stem cells to differentiate into functional pancreatic beta cells and acinar cells, reverse cell aging phenotype, reduce cell damage caused by oxidative stress and inflammation, and enhance pancreatic tissue repair ability; In terms of blood glucose regulation and metabolic improvement, it can optimize insulin secretion patterns, reduce insulin resistance, stabilize fasting blood glucose, postprandial blood glucose, and glycated hemoglobin levels, while regulating blood lipid profiles to reduce cardiovascular risks associated with metabolic syndrome; In terms of improving digestive function, it can significantly increase the secretion of digestive enzymes such as pancreatic lipase and trypsin, improve the digestion and absorption of fats, proteins, and carbohydrates, and alleviate various digestive discomforts caused by pancreatic dysfunction; In terms of anti-inflammatory and tissue protection, inhibiting the NF - κ B inflammatory signaling pathway can alleviate chronic inflammation and fibrosis of the pancreas, enhance intracellular antioxidant enzyme activity, and reduce free radical damage; In addition, it can also serve as a preventive intervention for middle-aged, elderly, and high-risk populations, delaying pancreatic function decline and metabolic aging, indirectly optimizing digestive and immune functions, and improving overall health status. The peptide has high tissue specificity, mild and long-lasting effects, and no significant toxic side effects at conventional doses. It has good safety and is suitable for various dosage forms such as freeze-dried powder, capsules, and injections.
